Literature DB >> 9024488

Molecular background of VS and weak C expression in blacks.

B H Faas1, E A Beckers, P Wildoer, P C Ligthart, M A Overbeeke, H A Zondervan, A E von dem Borne, C E van der Schoot.   

Abstract

BACKGROUND: The Rh system is complex and consists of as many as 45 different antigens. Red cells of about 25 percent of the black population carry VS an Rh-system antigen (Rh20), but this antigen is very rare in whites. VS positivity is always associated with a weak expression of e, and usually also of C. STUDY DESIGN AND METHODS: The RH genes of 11 black VS-positive donors were studied. Transcripts were sequenced for four VS-positive donors, three of whom had red cells with a weak expression of C. In the other donors, only analysis of genomic DNA was carried out.
RESULTS: The occurrence of VS was shown to be related to a single-point mutation in exon 5 of the RHCE gene (cytosine 733 guanine, leading to the Leu245Val substitution). The presence of this polymorphism in exon 5 may explain the simultaneously occurring weak e, because the E/e polymorphism is located in the same exon. Study of VS-positive donors with different Rh phenotypes showed that the polymorphism can occur in different alleles of the RHCE gene. In all three donors whose red cells showed a weak expression of C, a hybrid D-CE-D transcript was found, containing exon 4, 5, 6, 7, and (probably) 8 from the RHCE gene. No transcripts were encountered carrying DNA markers normally associated with C expression.
CONCLUSION: It is therefore postulated that the hybrid gene is responsible for the weak expression of C in these individuals. The hybrid gene carried a Leu62Phe substitution, as well as the Leu245Val substitution responsible for VS. The gene most probably cosegregates with a C allele encoding Cys 16 (normally encoded only by the C allele) and Val245 (responsible for VS antigenicity when encoded by the RHCE gene). This explains the combination of weak expression of C and VS positivity that is frequently found in blacks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024488     DOI: 10.1046/j.1537-2995.1997.37197176949.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  18 in total

1.  Insights into RHCE Molecular Analysis in Samples with Partial D Variants: the Experience of Western France.

Authors:  Yann Fichou; Cédric Le Maréchal; Virginie Scotet; Déborah Jamet; Claude Férec
Journal:  Transfus Med Hemother       Date:  2015-07-23       Impact factor: 3.747

2.  Two molecular polymorphisms to detect the (C)ce(s) type 1 haplotype.

Authors:  Willy A Flegel; Franz F Wagner
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

3.  Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease.

Authors:  Henrietta Enninful-Eghan; Reneé H Moore; Rebecca Ichord; Kim Smith-Whitley; Janet L Kwiatkowski
Journal:  J Pediatr       Date:  2010-09       Impact factor: 4.406

4.  Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania.

Authors:  Merita Xhetani; Irena Seferi; Claude Férec; Grigor Zoraqi; Yann Fichou
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

5.  (C)ce(s) haplotype screening in Tunisian blood donors.

Authors:  Hajer Moussa; Néjiba Ghommen; Houda Romdhane; Saadia Abdelkefi; Taher Chakroun; Batoul Houissa; Saloua Yacoub Jemni
Journal:  Blood Transfus       Date:  2013-12-04       Impact factor: 3.443

6.  Specific amino acid substitutions cause distinct expression of JAL (RH48) and JAHK (RH53) antigens in RhCE and not in RhD.

Authors:  Pirmin Schmid; Inge von Zabern; Erwin A Scharberg; Franz F Wagner; Willy A Flegel
Journal:  Transfusion       Date:  2010-01       Impact factor: 3.157

7.  DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter-Hipsky; Trina Whorley; Kim Hue-Roye; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2010-01-15       Impact factor: 3.157

8.  RhCE protein variants in Southwestern Germany detected by serologic routine testing.

Authors:  Peter Bugert; Erwin A Scharberg; Christof Geisen; Inge von Zabern; Willy A Flegel
Journal:  Transfusion       Date:  2009-05-18       Impact factor: 3.157

9.  Systematic RH genotyping and variant identification in French donors of African origin.

Authors:  Sandrine Kappler-Gratias; Carine Auxerre; Isabelle Dubeaux; Marylise Beolet; Maryline Ripaux; Pierre-Yves Le Pennec; Bach-Nga Pham
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

Review 10.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Authors:  Karina Yazdanbakhsh; Russell E Ware; France Noizat-Pirenne
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.